The UK’s Medicines and Healthcare products Regulatory Agency could lose around 20% of its 1,200-strong workforce under cost-cutting plans being drawn up to address post-Brexit revenue losses and other challenges.
The Pink Sheet understands that the plan to “transform” how the MHRA operates will lead to a reduction of approximately...








